SWX Swiss Exchange: Speedel Holding Ltd. Opens At CHF 125.00

Today, the shares of Speedel Holding Ltd., a Swiss biotech company, were traded in the main segment of the SWX Swiss Exchange for the first time. The opening price on the SWX was CHF 125.00. This corresponds to a market capitalisation of CHF 847.9 million. Speedel Holding Ltd. belongs to the SPI® and SPI EXTRA® and is also part of the novel sector specific indices SXI LIFE SCIENCES® and SXI Bio+Medtech®, which cover one of Switzerland's most prominent industries.

According to the listing prospectus, of the 6,783,405 registered shares entered in the Commercial Register, about 26 % are publicly held.

Speedel is a Swiss biopharmaceutical company that develops innovative therapies for cardiovascular and metabolic diseases. Speedel develops novel products from lead identification to the end of Phase II. For Phase III and commercialisation, the company either partners with big pharma or carries it out by itself.

Speedel Holding Ltd. currently employs 68 people. It made a net loss of CHF 34.567 million in the first semester of 2005.